AIA Group’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,902
Closed -$512K 389
2025
Q3
$512K Sell
6,902
-840
-11% -$85K 0.01% 343
2025
Q2
$1M Sell
7,742
-2,670
-26% -$387K 0.02% 226
2025
Q1
$1.66M Sell
10,412
-1,354
-12% -$245K 0.04% 190
2024
Q4
$2.18M Sell
11,766
-471
-4% -$91.4K 0.05% 147
2024
Q3
$2.58M Buy
12,237
+582
+5% +$101K 0.07% 138
2024
Q2
$1.56M Buy
11,655
+1,492
+15% +$282K 0.05% 182
2024
Q1
$2.18M Buy
+10,163
New +$1.99M 0.07% 130
2023
Q3
Sell
-2,688
Closed -$873K 309
2023
Q2
$873K Buy
+2,688
New +$768K 0.04% 187

Other funds holding INSP

AIA Group's INSP Position: Q4 2025 in Review

AIA Group sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 6,902 shares — an estimated $512K sold.

AIA Group first reported a position in INSP in Q2 2023 and held it in 8 quarters. The position peaked at $2.58M in Q3 2024. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • AIA Group reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • AIA Group sold 6,902 Inspire Medical Systems shares in Q4 2025, an estimated $512K.
  • AIA Group first reported a position in Inspire Medical Systems in Q2 2023 and held it in 8 quarters.
  • AIA Group's Inspire Medical Systems position peaked at $2.58M in Q3 2024.
  • 342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on AIA Group's 13F filing for Q4 2025, filed 9 Feb 2026.